PersonFounderExecutive
Michael Vidne
Michael Vidne is a Columbia-trained applied mathematician turned biotech founder who has spent the last decade moving cancer medicine from the lab bench to the clinic. He led the diagnostics company NovellusDx as CEO, steered its pivot into the precision-oncology drug developer Fore Biotherapeutics, and now builds at the intersection of AI, data, and healthcare as founder and CEO of the stealth-mode Baobab Therapeutics. His through-line: using rigorous models of complex systems - first neurons firing in the retina, later signaling pathways inside a tumor cell - to make treatment decisions that actually fit the patient in front of you.
michael vidnefore biotherapeuticsnovellusdxbaobab therapeuticsprecision oncologybiotech
